Zobrazeno 1 - 10
of 247
pro vyhledávání: '"Adithya Cattamanchi"'
Autor:
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Fred Welishe, Anne Nakitende, Lydia Akello, Lynn Kunihira Tinka, Jane Nakimuli, Joan Ritar Kasidi, Opira Bishop, Suzan Nakasendwa, Yeonsoo Baik, Devika Patel, Amanda Sammann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick Pj Phillips, Anne Katahoire, Christopher A Berger, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi
Publikováno v:
PLoS Medicine, Vol 21, Iss 2, p e1004356 (2024)
BackgroundExpanding access to shorter regimens for tuberculosis (TB) prevention, such as once-weekly isoniazid and rifapentine taken for 3 months (3HP), is critical for reducing global TB burden among people living with HIV (PLHIV). Our coprimary hyp
Externí odkaz:
https://doaj.org/article/5761700085894911af073cb22efadc18
Autor:
Priya B. Shete, Jillian L. Kadota, Grace Nanyunja, Catherine Namale, Talemwa Nalugwa, Denis Oyuku, Stavia Turyahabwe, Noah Kiwanuka, Adithya Cattamanchi, Achilles Katamba
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background Mitigating financial barriers to tuberculosis (TB) diagnosis and treatment is a core priority of the global TB agenda. We evaluated the impact of a cash transfer intervention on completion of TB testing and treatment initiation in Uganda.
Externí odkaz:
https://doaj.org/article/eff1a5a9be76407bbb168ecb53874127
Autor:
Adrienne Chang, Omary Mzava, Liz-Audrey Kounatse Djomnang, Joan Sesing Lenz, Philip Burnham, Peter Kaplinsky, Alfred Andama, John Connelly, Christine M. Bachman, Adithya Cattamanchi, Amy Steadman, Iwijn De Vlaminck
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Tuberculosis (TB) remains a significant cause of mortality worldwide. Metagenomic next-generation sequencing has the potential to reveal biomarkers of active disease, identify coinfection, and improve detection for sputum-scarce or culture-n
Externí odkaz:
https://doaj.org/article/28d3eaa4844b454997e0d52a41374b20
Autor:
Alexandra J. Zimmer, César Ugarte-Gil, Rahul Pathri, Puneet Dewan, Devan Jaganath, Adithya Cattamanchi, Madhukar Pai, Simon Grandjean Lapierre
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-8 (2022)
Zimmer et al. discuss the importance of cough assessment in clinical management of tuberculosis (TB). They describe how acoustic epidemiology, which uses recording devices and artificial intelligence to detect, record and analyze cough, can be used i
Externí odkaz:
https://doaj.org/article/a643ddd5a2334e8aa2370c21f19b9e7a
Autor:
Claudia M Denkinger, Adithya Cattamanchi, Seda Yerlikaya, Lydia Marie-Luise Holtgrewe, Tobias Broger, Chris Isaacs, Payam Nahid
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Introduction In 2014, the WHO published high-priority target product profiles (TPPs) for new tuberculosis (TB) diagnostics to align end-user needs with test targets and specifications; nevertheless, no TB test meets these targets to date. The COVID-1
Externí odkaz:
https://doaj.org/article/c1b7582c8d4a42468aef0760cddb0eee
Autor:
Stella Zawedde-Muyanja, Joseph Musaazi, Barbara Castelnuovo, Adithya Cattamanchi, Achilles Katamba, Yukari C Manabe
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0265035 (2022)
BackgroundOne in five patients diagnosed with TB in Uganda are not initiated on TB treatment within two weeks of diagnosis. We evaluated a multifaceted intervention for improving TB treatment initiation among patients diagnosed with TB using Xpert®
Externí odkaz:
https://doaj.org/article/72910ef97a67436188d362c71f145086
Autor:
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Juliet Nabunje, Fred Welishe, Anne Nakitende, Lydia Akello, Opira Bishop, Devika Patel, Amanda Sammann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick P J Phillips, Anne Katahoire, Christopher A Berger, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi
Publikováno v:
PLoS Medicine, Vol 18, Iss 12, p e1003875 (2021)
BackgroundScaling up shorter regimens for tuberculosis (TB) prevention such as once weekly isoniazid-rifapentine (3HP) taken for 3 months is a key priority for achieving targets set forth in the World Health Organization's (WHO) END TB Strategy. Howe
Externí odkaz:
https://doaj.org/article/7ef8024b3f924c37b7473ac822998ef2
Autor:
Adithya Cattamanchi, Rebecca Crowder, Alex Kityamuwesi, Noah Kiwanuka, Maureen Lamunu, Catherine Namale, Lynn Kunihira Tinka, Agnes Sanyu Nakate, Joseph Ggita, Patricia Turimumahoro, Diana Babirye, Denis Oyuku, Christopher Berger, Austin Tucker, Devika Patel, Amanda Sammann, Stavia Turyahabwe, David Dowdy, Achilles Katamba
Publikováno v:
PLoS Medicine, Vol 18, Iss 5, p e1003628 (2021)
BackgroundAdherence to and completion of tuberculosis (TB) treatment remain problematic in many high-burden countries. 99DOTS is a low-cost digital adherence technology that could increase TB treatment completion.Methods and findingsWe conducted a pr
Externí odkaz:
https://doaj.org/article/5f0095f052294c30b52c271429a95179
Autor:
Liza M. de Groot, Masja Straetemans, Noriah Maraba, Lauren Jennings, Maria Tarcela Gler, Danaida Marcelo, Mirchaye Mekoro, Pieter Steenkamp, Riccardo Gavioli, Anne Spaulding, Edwin Prophete, Margarette Bury, Sayera Banu, Sonia Sultana, Baraka Onjare, Egwuma Efo, Jason Alacapa, Jens Levy, Mona Lisa L. Morales, Achilles Katamba, Aleksey Bogdanov, Kateryna Gamazina, Dzhumagulova Kumarkul, Orechova-Li Ekaterina, Adithya Cattamanchi, Amera Khan, Mirjam I. Bakker
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 7, Iss 5, p 65 (2022)
Worldwide, non-adherence to tuberculosis (TB) treatment is problematic. Digital adherence technologies (DATs) offer a person-centered approach to support and monitor treatment. We explored adherence over time while using DATs. We conducted a meta-ana
Externí odkaz:
https://doaj.org/article/64ef98f512544b1b850357a0fafd4378
Autor:
Rachel K Lim, Fred C Semitala, Elly Atuhumuza, Laban Sabiti, Jane Namakula-Katende, Winnie R Muyindike, Moses R Kamya, David Dowdy, Adithya Cattamanchi
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246113 (2021)
A 12-dose weekly regimen of rifapentine plus isoniazid (3HP) is recommended for the prevention of active tuberculosis (TB); however, it is unclear whether 3HP should be provided by directly observed therapy (DOT) or self-administered therapy (SAT). I
Externí odkaz:
https://doaj.org/article/49183bb919474579bb1837cc44e17745